Worried About a Market Crash? This Dividend Stock Outperformed as the S&P 500 Sank in Both 2008 and 2022

Investors often express concern about the prospect of a market downturn, particularly when macroeconomic indicators such as inflation and rising energy prices loom large. While it remains uncertain whether these issues will persist enough to trigger a bear market, it is prudent to consider investments that may perform relatively well even in the face of economic challenges. One such example is Amgen (NASDAQ: AMGN), a pharmaceutical company that has demonstrated resilience during market crashes.

To illustrate Amgen's performance, we can examine its behavior during two significant market downturns: the Great Recession, which occurred from December 2007 to June 2009, and the more recent downturn in 2022. Throughout the entire 2008 recession, when the S&P 500 suffered substantial losses, Amgen's stock remained in the red but outperformed the broader market. Moreover, during the specific year of 2008, the year that saw the most significant damage to the S&P 500, Amgen actually gained value.

This track record of outperforming the broader market during times of economic distress makes Amgen an attractive option for investors seeking to hedge against potential market crashes.